| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Genetics, Vol. 169, 1343-1352, March 2005, Copyright © 2005
doi:10.1534/genetics.104.037143
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


* Department of Environmental Health Sciences, Columbia University, Mailman School of Public Health, New York, New York 10032
Institute for Cellular and Molecular Biology, University of Texas, Austin, Texas 78712
1 Corresponding author: Department of Environmental Health Sciences, Columbia University, Mailman School of Public Health, 60 Haven Ave., B-1, New York, NY 10032.
E-mail: lz2115{at}columbia.edu
| ABSTRACT |
|---|
|
|
|---|
The mechanism of transcriptional activation by Hap1 has been intensely investigated (CREUSOT et al. 1988; PFEIFER et al. 1989; ZHANG and HACH 1999). Hap1 binds to DNA via a C6 zinc cluster motif, which is located near the N terminus and is found in members of the Gal4 transcriptional regulator family (CREUSOT et al. 1988; PFEIFER et al. 1989). Like Gal4, Hap1 binds as a dimer to DNA containing two CGG triplets, with each C6 zinc cluster motif recognizing one CGG (ZHANG and GUARENTE 1994c, 1996). However, unlike Gal4, which binds to symmetrical DNA sites containing an inverted repeat of two CGGs, Hap1 binds to asymmetric sites containing a direct repeat of two CGGs (optimal sequence, CGGnnnTAnCGG; ZHANG and GUARENTE 1994c, 1996). Hap1 transcription-activating activity is conferred by its acidic activation domain located at its C terminus (PFEIFER et al. 1989).
Hap1 transcription-activating activity is precisely controlled by intracellular heme concentration (CREUSOT et al. 1988; PFEIFER et al. 1989; ZHANG and HACH 1999). Previous work showed that the regulation of Hap1 activity by heme involves a two-tier regulatory mechanism: inactivation in the absence of heme and activation by heme (HACH et al. 1999; ZHANG and HACH 1999; HON et al. 2000). Hap1 inactivation in the absence of heme requires the proper functioning of a class of Hap1 elements, repression modules (RPM13), and the molecular chaperone Hsp70 and cochaperones (HACH et al. 1999; HON et al. 2001). Disrupting the function of RPMs or Hsp70 causes Hap1 to gain high levels of activity in the absence of heme (HACH et al. 1999; HON et al. 2001). Hap1 activation by heme is mediated by another class of Hap1 elements, heme-responsive motifs (HRM16 and HRM7), and the molecular chaperone Hsp90 (HACH et al. 1999; HON et al. 2000; LEE et al. 2002, 2003). Particularly, HRM7 plays a predominant role, while HRM16 play an auxiliary role, in heme activation (HACH et al. 1999; LEE et al. 2003).
Previous evidence suggests that Hap1 represses transcription of several genes, including ROX1 and ERG11 (VERDIERE et al. 1991; DEFRANOUX et al. 1994; DECKERT et al. 1995; PINKHAM et al. 1997), in the absence of heme. However, there is no direct evidence showing that Hap1 binds to the promoters of these genes and promotes repression. Furthermore, it is unclear how Hap1 may repress transcription. Does transcriptional repression by Hap1 also involve Hap1 elements HRMs and RPMs and molecular chaperones? Is DNA binding necessary for repression by Hap1? In this report, to answer these questions, we explore the possibility of the repression of the HAP1 gene by Hap1. We found that Hap1 indeed strongly represses the transcription of its own gene and that it does so by a heme-independent mechanism distinct from its mechanism of transcriptional activation.
| MATERIALS AND METHODS |
|---|
|
|
|---|
trp1 (MATa, ura3-52, leu2-3, 112, his4-519, ade1-100, trp1::HisG; wild-type control for
hap1), L51 (MATa, ura3-52, leu2-3, 112, his4-519, ade1-100, trp1::HisG, hap1::LEU2) (
hap1; ZHANG and GUARENTE 1994a), MHY100 (MATa, ura3-52, leu2-3, 112, his4-519, ade1-100, hem1-
100) (
hem1; HALDI and GUARENTE 1989), MHY200 (MATa, ura3-52, leu2-3, 112, his4-519, ade1-100, hem1-
100, hap1::LEU2) (
hap1
hem1; HALDI and GUARENTE 1995), JN55 (MATa, ura3-52, leu2-3, 112, his3-11, trp1
1, lys2) (wild-type control for a2a3a4), JN516 (MATa, ura3-52, leu2-3, 112, his3-11, trp1
1, lys2, ssa2::LEU2, ssa3::TRP1, ssa4::LYS2) (a2a3a4; BECKER et al. 1996), W303 (MAT
, can1-100, ade2-1, his3-11,15, leu2-3,112, trp1-1, ura3-1) (wild-type control for iLEP), and iLEP (MAT
, can1-100, ade2-1, his3-11,15, leu2-3,112, trp1-1, ura3-1, hsc82::LEU2, hsp82::LEU2, pLEP1HSP82; CHANG and LINDQUIST 1994). The full-length HAP1 promoter-lacZ reporter H1 (Table 1 and Figures 1, 2, and 5) and the reporter H2H4 (Figure 2) were constructed by inserting the indicated DNA fragment containing the full-length or part of the HAP1 promoter into the pLG178 reporter plasmid (GUARENTE and MASON 1983; GUARENTE et al. 1984) digested with BamHI and XhoI. The resulting reporter plasmids do not contain the promoter of the CYC1 gene present in pLG178. The plasmids were confirmed by restriction digestion and sequencing. The reporter plasmid C1 was constructed by inserting the indicated DNA fragment containing part of the HAP1 promoter into the pLG178 reporter plasmid (GUARENTE and MASON 1983; GUARENTE et al. 1984) digested with SmaI and XhoI. The resulting reporter plasmid contains the basal promoter of the CYC1 gene present in pLG178. The pLG178 reporter plasmid contains only the basal promoter elements of the CYC1 gene (1 to 178) and no upstream activation sequence (UAS; GUARENTE and MASON 1983; GUARENTE et al. 1984) and exhibits a low, basal level activity in all cells used here and elsewhere (GUARENTE and MASON 1983; GUARENTE et al. 1984; LEE et al. 2002). All expression plasmids for Hap1 and mutants have been described previously (PFEIFER et al. 1989; ZHANG and GUARENTE 1994a; HACH et al. 1999; LEE et al. 2003).
|
|
|
-aminolevulinate to an optical density (OD) of
1.0. Cells were harvested for determination of ß-galactosidase activity as described (ZHANG et al. 1998; HON et al. 2000). ß-Galactosidase levels from the UAS1/CYC1-lacZ reporter (GUARENTE et al. 1984; TURCOTTE and GUARENTE 1992) and the HAP1 promoter reporter gene with deletions were similarly measured. The UAS1/CYC1-lacZ reporter contains the UAS1 sequence, to which Hap1 binds with high affinity and promotes transcription, and the basal CYC1 promoter sequence 1 to 178 (GUARENTE and MASON 1983; GUARENTE et al. 1984). SEMs were calculated from data from at least three independent transformants.
Preparation of yeast extracts and purified GST-Hap1 and electrophoretic mobility shift assays:
Extracts were prepared according to previously established protocols (ZHANG and GUARENTE 1994b; ZHANG et al. 1998). Briefly, yeast cells were grown to OD 0.8, harvested, and resuspended in 3 packed cell volumes of buffer (20 mM Tris, 10 mM MgCl2, 1 mM EDTA, 10% glycerol, 1 mM DTT, 0.3 M NaCl, 1 mM phenylmethylsulfonyl fluoride, 1 µg/ml pepstatin, and 1 µg/ml leupeptin). Cells bearing the GAL1-driven HAP1 expression vector (TURCOTTE and GUARENTE 1992) were induced by 2% galactose for 56 hr prior to collection, as described (HACH et al. 1999). Cells were then permeabilized by agitation with 4 packed cell volumes of glass beads, and extracts were collected. Protein concentrations were subsequently determined by Bradford assay.
The GST-Hap1 fusion protein (Figure 3) containing GST residues 1222 and Hap1 residues 1171 was expressed and purified from Escherichia coli (ZHANG and GUARENTE 1994c). The construction of the expression plasmid was described previously (ZHANG and GUARENTE 1994c), and its purification was carried out exactly as described (ZHANG and GUARENTE 1994c). DNA-binding reactions were carried out in a 20-µl volume with 5% glycerol, 4 mM Tris, pH 8, 40 mM NaCl, 4 mM MgCl2, 10 mM DTT, 1.5 µg salmon sperm DNA, 10 µM ZnOAc2, and 300 µg/ml BSA as described (ZHANG and GUARENTE 1994b; ZHANG et al. 1998; HON et al. 2000). Approximately 0.01 pmol of labeled DNA and 20 µg of protein extracts were used in each reaction. The Hap1 antibodies were included in reaction mixtures as described previously (ZHANG et al. 1993). The reaction mixtures were incubated at 4° for 1 hr and then loaded onto 4% polyacrylamide gels in 1/3 TBE for gel electrophoresis at 4°. Radioactivity of the interested bands was visualized and quantified by using the PhosphoImage system (Molecular Dynamics, Sunnyvale, CA).
|
Microarray analysis of DNA pulled down by chromatin immunoprecipitation:
Yeast MHY100 cells bearing the Hap1 expression plasmid under the control of the GAL1/10 promoter were grown under high- and low-heme conditions and were used for chromatin immunoprecipitation, as described above. To determine the genome-wide binding distribution of Hap1 by ChIP-chip, we amplified and labeled the ChIP samples with Cy5 as described before (IYER et al. 2001; HAHN et al. 2004). Genomic DNA from the same strain was labeled in parallel with Cy3 and used as the reference sample. Fluorescently labeled ChIP samples were simultaneously hybridized to whole-genome yeast arrays containing nearly all ORFs and intergenic sequences as described previously (IYER et al. 2001; HAHN et al. 2004). Microarrays were scanned with a GenePix 4000B scanner (Axon Instruments, Foster City, CA), and fluorescent intensities were quantified by using GenePix pro software (version 4). Data were normalized and filtered, and spots with obvious defects or with signals below an empirically determined threshold were excluded. Further data analyses were performed by using the Longhorn Array database (KILLION et al. 2003). The Cy5-to-Cy3 fluorescent signal ratio of each locus represents the fold of enrichment. The ChIP enrichment score E for each locus is calculated as follows: E = median R(Cy5/Cy3)1, R(Cy5/Cy3)2, R(Cy5/Cy3)3 ... R(Cy5/Cy3)n. R(Cy5/Cy3)i is the percentile rank of the Cy5-to-Cy3 ratio of each locus among all genomic loci in the ith independent ChIP experiment (KILLION et al. 2003; KIM and IYER 2004). Those with enrichment scores of >96% (median percentile ranking) are considered significant.
| RESULTS |
|---|
|
|
|---|
hap1 cells with the HAP1 gene deleted, the HAP1-lacZ reporter activity was >20-fold higher than that in the corresponding wild-type cells (Table 1). For controls, we showed that the activity of the Hap1-activated UAS1/CYC1-lacZ reporter was high in wild-type cells, but low in
hap1 cells, as expected. This result shows that Hap1 greatly represses the transcription of the HAP1 gene. To determine whether the repression of the HAP1 gene by Hap1 depends on heme levels, we detected the HAP1-lacZ reporter activity in
hem1 and
hem1
hap1 cells grown under heme-deficient and heme-sufficient conditions (Table 1). We found that regardless of heme levels, the HAP1-lacZ reporter activity was low (repressed) in
hem1 cells, but high (derepressed) in
hem1
hap1 cells (Table 1). As expected, the activity of the Hap1-activated UAS1/CYC1-lacZ reporter was high in wild-type cells or in
hem1 cells grown at high heme levels, but was very low in
hap1 cells or in
hem1 cells grown at low heme levels or in
hem1
hap1 cells grown at both low and high heme levels (Table 1). These results show that the repression of the HAP1 gene is dependent on Hap1, but independent of heme levels.
Hap1 DNA binding is important for transcriptional repression by Hap1:
To better understand the mechanism of transcriptional repression by Hap1, we asked whether Hap1 domains critical for transcriptional activation and heme regulation are also important for transcriptional repression by Hap1. We measured and compared the repression activity of wild-type Hap1, the Hap1-18 mutant, and Hap1 proteins with various domains deleted (Figure 1A; KIM and GUARENTE 1989; PFEIFER et al. 1989; HACH et al. 1999). All these Hap1 proteins are shown to be stably expressed at high levels in yeast (PFEIFER et al. 1987; HACH et al. 1999; Figure 1B). Notably, mutant Hap1-18 was largely defective in the repression of the HAP1 promoter (Figure 1, Hap1-18). Hap1-18 contains a Ser-to-Arg mutation at amino acid position 63 in the zinc cluster motif (KIM and GUARENTE 1989; TURCOTTE and GUARENTE 1992); it binds only to the UAS/CYC7 site (CGCTATTATCGCTATTA), not the typical Hap1-binding sites (optimal: CGGnnnTAnCGG) (ZHANG and GUARENTE 1994c). Therefore, this result from Hap1-18 shows that Hap1 DNA binding is necessary for transcriptional repression by Hap1.
The Hap1 heme domain has little effect on transcriptional repression by Hap1:
Hap1 domains critical for transcriptional activation and for heme regulation exerted varying effects on the repression activity of Hap1 (Figure 1). Notably, deletion of the heme domain, containing both the repression module RPM1 and heme-responsive motifs HRM16 (Figure 1,
heme), virtually did not affect the repression activity of Hap1. This result, together with those in Table 1, demonstrates that the repression function of Hap1, unlike its activation function, is completely heme independent.
Interestingly, the deletion of the Hap1 activation domain caused a fivefold derepression of the HAP1 promoter (Figure 1A, HK). As the deleted region enlarges in HB and HG, Hap1 repression capacity further diminishes (Figure 1A). Due to lack of the activation domain, these deletion proteins were inactive at the UAS1/CYC1 site mediating transcriptional activation by Hap1 (see Figure 1, the UAS1/CYC1 column). The H7-d1 and H7-d2 deletion proteins, which cause Hap1 derepression in the absence of heme and exhibit higher transcriptional activity at UAS1/CYC1 (HACH et al. 1999; see also Figure 1, the UAS1/CYC1 column), were partially defective in Hap1 transcriptional repression. The smHap1 mutant protein (Figure 1), which is completely transcriptionally inactive and heme inactivable (LEE et al. 2003), completely lost its ability to repress the HAP1 gene. The data show that the Hap1 activation domain is required not only for transcriptional activation, but also for repression, although to a lesser extent. It appears that other than the DNA-binding domain, the activation domain and other internal domains of Hap1 all contribute to transcriptional repression, while the activation domain is both necessary and sufficient for transcriptional activation, as shown previously (PFEIFER et al. 1989).
Hap1 appears to bind to the HAP1 promoter and promotes repression directly:
To better understand how Hap1 represses transcription of the HAP1 gene, we tried to map the DNA site responsible for transcriptional repression. To this end, we constructed three 5'-end deletions (Figure 2, H1, H2, and H3), one internal deletion (H4), and one 3'-end deletion (C1) of the HAP1 promoter. The basal promoter elements for the 3'-end deletions are supplied by using the basal promoter of the CYC1 gene. We were unable to construct a reporter containing the complete HAP1 promoter and the basal CYC1 promoter even after repeated attempts, very likely because the repeated AT-rich regions in these promoters cause the construct to be unstable in E. coli.
Nonetheless, the deletion analysis provides important clues about transcriptional repression by Hap1 (Figure 2). The results show that a UAS is likely located around the nucleotide 380 region, because reporter constructs lacking sequences upstream or downstream of 380 were inactive in cells expressing Hap1 (Figure 2, HAP1) and in cells with the HAP1 gene deleted (Figure 2,
hap1). It is not clear whether this region contains the DNA site mediating repression, because the absence of a UAS makes it impossible to identify the site by derepression in cells lacking Hap1. However, reporter construct C1 lacking sequence from nucleotide 150 to 1 exhibited high activity even in cells expressing wild-type Hap1, suggesting that the 150 to 1 region contains part of the or the whole site mediating repression by Hap1 (Figure 2). The site mediating Hap1 repression may overlap with sequence beyond 150 (the reporter C1 may contain part of the repression site and still be derepressed), but should not overlap the coding region beyond 1. These results show that the HAP1 promoter contains a DNA site responsible for transcriptional repression.
The HAP1 promoter does not have a Hap1-binding site containing an indirect repeat of two CGG/CGC triplets separated by a 6-bp spacer, which is found in promoters that are activated by Hap1 (ZHANG and GUARENTE 1994c). However, the promoter contains at least 10 CGG/CGC half-sites (sequence from the SGD). These sites can make contacts with a Hap1 monomer or a subunit of a Hap1 dimer or oligomer in a repression complex with another protein partner. To ascertain whether Hap1 actually binds to the HAP1 promoter directly, we performed electrophoretic mobility shift assays. We generated radiolabled and unlabeled DNA fragments containing various regions of the HAP1 gene promoter, as described previously (ZHANG and GUARENTE 1994c). All DNA fragments containing sequence between 300 and 50 showed at least one Hap1-bound complex when incubated with extracts prepared from cells expressing Hap1. Particularly, the DNA fragment containing 300 to 50 of the HAP1 promoter revealed a specific Hap1-binding activity by wild-type Hap1 in extracts or by purified GST-Hap1 (residues 1171) fusion protein (ZHANG and GUARENTE 1994c; see Figure 3).
As shown in Figure 3, a specific Hap1-DNA complex was formed when radiolabled 300 to 50 fragments were incubated with extracts prepared from cells expressing Hap1 (see Figure 3, lane 2). This band was largely disrupted by addition of Hap1 antibodies (Figure 3, compare lanes 4 and 2), but not the preimmune serum (Figure 3, lane 3; ZHANG et al. 1993). Quantification showed that the intensity of the band was reduced by fivefold by antibodies but slightly increased by preimmune serum. This band was also titrated out fully by unlabeled DNA fragments containing the typical high-affinity Hap1-binding site 7/1 (Figure 3, lane 5) or by unlabeled DNA fragments containing the promoter sequence (Figure 3, lanes 6 and 7). The band intensity was reduced >20-fold by the competitor DNA. For a control, we showed that no specific protein binding was detected when extracts prepared from
hap1 cells were used in the assay (see Figure 3, lane 1). Notably, a specific Hap1-DNA complex was also formed when the 300 to 50 fragment was incubated with a purified GST-Hap1 (residues 1171) fusion protein (see Figure 3, lanes 9 and 10). However, this result showing binding by the purified Hap1 fragment (
100 nM and at 4°) does not exclude the possibility that non-Hap1 proteins cobind with Hap1 at the HAP1 promoter in extracts or in vivo.
Further, by chromatin immunoprecipitation assays (ORLANDO 2000; IYER et al. 2001) with purified anti-Hap1 antibodies (Figure 4; ZHANG et al. 1998), coupled to DNA microarray hybridization (ChIP-chip), we showed that Hap1 is associated with the promoter of the HAP1 gene preferentially in vivo. Chromatin-immunoprecipitated DNAs were obtained from a strain where Hap1 is expressed from the GAL1/10 promoter. Chromatin-immunoprecipitated DNAs were first randomly amplified and then labeled with Cy5. Genomic DNAs from the same cells were amplified and labeled with Cy3 as a reference. The immunoprecipitated and reference DNAs were simultaneously hybridized to whole-genome arrays containing both ORFs and intergenic sequences. The microarrays were scanned, and data analyses were performed by using the Longhorn Array database (KILLION et al. 2003). The fold of enrichment for each locus was obtained by calculating the ratio of Cy5 to Cy3 fluorescent intensities (red/green) at the corresponding locus in the ChIP experiments. To identify the most strongly and consistently enriched loci we determined the median percentile ranks (enrichment scores) of ChIP enrichment across multiple (nine in this case) independent replicate experiments as described before (HAHN et al. 2004; KIM and IYER 2004). Within the top 2% of enriched loci across nine independent ChIP-chip experiments, we found that the two loci (Figure 4, iYLR255C and YLR256W) that contain part of the HAP1 gene were consistently immunoprecipitated. The fold of enrichment for the YLR256W, iYLR255C, and iYLRWdelta loci, shown in Figure 4, was 5.1±1.6, 3.5±0.9, and 4.8±2.2, respectively. The fold of enrichment for the CYC1 locus, which binds to Hap1 with high affinity and is strongly activated by Hap1, was 5.8±2.4. Several other known Hap1-regulated genes, including CYT1 (SCHNEIDER and GUARENTE 1991), MOT3 (SERTIL et al. 2003), and COX15 (CHOI et al. 1996), were also found to be repeatedly enriched in the ChIP-chip experiments. Also, PCR amplification of immunoprecipitated DNAs by Hap1 antibodies with primers flanking the HAP1 promoter region repeatedly generated the expected product while no specific product was detected if primers flanking the coding sequence of the SSA1 gene were used or if Hap1 was not expressed. Quantification showed that the level of PCR product from the HAP1 genes was at least 15-fold higher than the background level from PCR amplification of the SSA1 gene. These results strongly support the idea that Hap1 can directly bind to its own promoter in vivo. Together with data in Figures 13, these results demonstrate that Hap1 binds specifically to DNA in the HAP1 promoter region mediating transcriptional repression.
|
|
| DISCUSSION |
|---|
|
|
|---|
How does Hap1 repress transcription? The mechanism by which Hap1 represses transcription is distinct from its mechanism of transcriptional activation, while they may share common characteristics. First, the repression function of Hap1 is heme independent whereas the activation function of Hap1 is heme dependent. This does not necessarily suggest that the repression function of Hap1 is irrelevant to transcriptional activation by Hap1. The repression function of Hap1 may greatly enhance its ability to precisely control transcription. For example, repression may be the default function in heme-deficient cells and may be part of heme regulation. By transforming from a repressor in the absence of heme to an activator in the presence of heme, Hap1 may exert a much greater degree of control on transcription than a simple activator, as in the case of ROX1 expression (ZHANG and HACH 1999).
Second, the Hap1 activation domain is also required for its repressing function although its role is less dominant in repression than in activation. In addition to the DNA-binding domain, the Hap1 activation domain is both necessary and sufficient for transcriptional activation (PFEIFER et al. 1989). Repression by Hap1 appears to depend not only on the activation domain, but also on the internal domains (Figure 1). No single domain appears to play a dominant role in repression (Figure 1). Rather, all Hap1 domains appear to act together to exert a collective control over its repression function. Nevertheless, the finding that the Hap1 activation domain plays a role in both transcriptional activation and repression is intriguing. Recent studies indicate that certain coactivator complexes may also have a repressing function. For example, the Swi/Snf coactivator complex can directly repress transcription, although the requirement for specific components may differ in repression, compared to activation (MARTENS and WINSTON 2002, 2003). Thus, it is conceivable that the Hap1 activation domain is necessary to recruit its coactivator complex, while it can also help recruit its corepressor complex, because the coactivator and corepressor share a common component(s). Consistent with this idea, previous experiments (HA et al. 2000) suggest that Swi2 plays a positive role in transcriptional activation by Hap1. Thus, the Hap1 activation domain may help recruit coactivator and corepressor complexes like the Swi/Snf complexes, thereby promoting both transcriptional activation and repression.
Third, the requirement for protein partners for repression and activation is different. While Hsp90 is critical for transcriptional activation by Hap1 (ZHANG et al. 1998; LEE et al. 2002), it does not appear to be important for repression by Hap1. Ssa, however, appears to cooperate with Hap1 in transcriptional repression. This role of Ssa is consistent with its role in general protein folding and in the inactivation of Hap1 transcription-activating function in the absence of heme (HON et al. 2001; HARTL and HAYER-HARTL 2002).
In addition to Ssa, Hap1 may require one more protein for repressing transcription. This protein likely cooperates with Hap1 in DNA binding and perhaps in repression. The HAP1 promoter does not contain a full Hap1-binding site for a Hap1 dimer (a direct repeat of two CGG/CGC triplets with a 6-bp spacer; ZHANG and GUARENTE 1994c), but it contains many single CGG/CGCs that can make contacts with a Hap1 monomer or a subunit of a Hap1 dimer/oligomer. Either CGG or CGC may be involved in Hap1 binding, because Hap1 can bind to both triplets well (PFEIFER et al. 1987; HON et al. 1999; KING et al. 1999) and because Hap1-18 also conferred a slight (less than twofold) repression on the HAP1 promoter (Figure 1). Hap1 monomer-DNA contacts may be an essential part of a Hap1-DNA repression complex. Indeed, purified GST-Hap1 (residues 1171; Figure 3), at a concentration of
100 nM and at 4°, can bind to the HAP1 promoter in vitro. However, this result does not exclude the possibility that in vivo, and even in extracts, Hap1 binds to the HAP1 promoter cooperatively with another corepressor. This corepressor may contact DNA and may bind to DNA cooperatively to enhance the DNA-binding affinity of the repressor complex. Hap1 may repress transcription by many mechanisms. For example, like glucocorticoid receptor (GR; MINER et al. 1991), Hap1 may bind to composite DNA sites with other factor(s) and thereby repress transcription. Alternatively, Hap1 may recruit a transcriptional repressor and thereby repress transcription. Or Hap1 may displace binding of another activator.
The repression function of Hap1 is likely to be important for many genes other than HAP1. Recent gene expression analyses show that >100 genes (LOMBARDIA et al. 2000), including ANB1 and HEM13, exhibit increased transcript levels in cells with HAP1 deleted, compared to wild-type cells (also T. HON and L. ZHANG, unpublished results). Although the effect of Hap1 on both ANB1 and HEM13 appears to be indirect (ZITOMER et al. 1997; MENNELLA et al. 2003), Hap1 may bind to and repress directly transcription of at least some of these genes. The mechanism of transcriptional repression by Hap1 may have general implications in understanding the regulation of numerous genes in yeast. The mechanisms by which Hap1 activates and represses transcription may provide insights into the mechanisms by which many other characterized and uncharacterized transcriptional regulators, such as Rap1 (MORSE 2000), activate and repress transcription.
| ACKNOWLEDGEMENTS |
|---|
|
|
|---|
| LITERATURE CITED |
|---|
|
|
|---|
BECKER, J., W. WALTER, W. YAN and E. A. CRAIG, 1996 Functional interaction of cytosolic hsp70 and a DnaJ-related protein, Ydj1p, in protein translocation in vivo. Mol. Cell. Biol. 16: 43784386.[Abstract]
BUISSON, N., and R. LABBE-BOIS, 1998 Flavohemoglobin expression and function in Saccharomyces cerevisiae. No relationship with respiration and complex response to oxidative stress. J. Biol. Chem. 273: 95279533.
CHANG, H. C., and S. LINDQUIST, 1994 Conservation of Hsp90 macromolecular complexes in Saccharomyces cerevisiae. J. Biol. Chem. 269: 2498324988.
CHOI, J. Y., J. STUKEY, S. Y. HWANG and C. E. MARTIN, 1996 Regulatory elements that control transcription activation and unsaturated fatty acid-mediated repression of the Saccharomyces cerevisiae OLE1 gene. J. Biol. Chem. 271: 35813589.
CREUSOT, F., J. VERDIERE, M. GAISNE and P. P. SLONIMSKI, 1988 CYP1 (HAP1) regulator of oxygen-dependent gene expression in yeast. I. Overall organization of the protein sequence displays several novel structural domains. J. Mol. Biol. 204: 263276.[CrossRef][Medline]
DECKERT, J., R. PERINI, B. BALASUBRAMANIAN and R. S. ZITOMER, 1995 Multiple elements and auto-repression regulate Rox1, a repressor of hypoxic genes in Saccharomyces cerevisiae. Genetics 139: 11491158.[Abstract]
DEFRANOUX, N., M. GAISNE and J. VERDIèRE, 1994 Functional analysis of the zinc cluster domain of the CYP1 (HAP1) complex regulator in heme-sufficient and heme-deficient yeast cells. Mol. Gen. Genet. 242: 699707.[Medline]
FORSBURG, S. L., and L. GUARENTE, 1989 Identification and characterization of HAP4: a third component of the CCAAT-bound HAP2/HAP3 heteromer. Genes Dev. 3: 11661178.
GUARENTE, L., and T. MASON, 1983 Heme regulates transcription of the CYC1 gene of S. cerevisiae via an upstream activation site. Cell 32: 12791286.[CrossRef][Medline]
GUARENTE, L., B. LALONDE, P. GIFFORD and E. ALANI, 1984 Distinctly regulated tandem upstream activation sites mediate catabolite repression of the CYC1 gene of S. cerevisiae. Cell 36: 503511.[CrossRef][Medline]
HA, N., K. HELLAUER and B. TURCOTTE, 2000 Fusions with histone H3 result in highly specific alteration of gene expression. Nucleic Acids Res. 28: 10261035.
HACH, A., T. HON and L. ZHANG, 1999 A new class of repression modules is critical for heme regulation of the yeast transcriptional activator Hap1. Mol. Cell. Biol. 19: 43244333.
HAHN, J. S., Z. HU, D. J. THIELE and V. R. IYER, 2004 Genome-wide analysis of the biology of stress responses through heat shock transcription factor. Mol. Cell. Biol. 24: 52495256.
HALDI, M., and L. GUARENTE, 1989 N-terminal deletions of a mitochondrial signal sequence in yeast. Targeting information of delta-aminolevulinate synthase is encoded in non-overlapping regions. J. Biol. Chem. 264: 1710717112.
HALDI, M. L., and L. GUARENTE, 1995 Multiple domains mediate heme control of the yeast activator HAP1. Mol. Gen. Genet. 248: 229235.[CrossRef][Medline]
HARTL, F. U., and M. HAYER-HARTL, 2002 Molecular chaperones in the cytosol: from nascent chain to folded protein. Science 295: 18521858.
HINNEBUSCH, A. G., 1984 Evidence for translational regulation of the activator of general amino acid control in yeast. Proc. Natl. Acad. Sci. USA 81: 64426446.
HON, T., A. HACH, D. TAMALIS, Y. ZHU and L. ZHANG, 1999 The yeast heme-responsive transcriptional activator Hap1 is a preexisting dimer in the absence of heme. J. Biol. Chem. 274: 2277022774.
HON, T., A. HACH, H. C. LEE, T. CHEN and L. ZHANG, 2000 Functional analysis of heme regulatory elements of the transcriptional activator Hap1. Biochem. Biophys. Res. Commun. 273: 584591.[CrossRef][Medline]
HON, T., H. C. LEE, A. HACH, J. L. JOHNSON, E. A. CRAIG et al., 2001 The Hsp70-Ydj1 molecular chaperone represses the activity of the transcriptional activator Hap1 in the absence of heme. Mol. Cell. Biol. 21: 79237932.
IYER, V. R., C. E. HORAK, C. S. SCAFE, D. BOTSTEIN, M. SNYDER et al., 2001 Genomic binding sites of the yeast cell-cycle transcription factors SBF and MBF. Nature 409: 533538.[CrossRef][Medline]
KILLION, P. J., G. SHERLOCK and V. R. IYER, 2003 The Longhorn Array Database (LAD): an open-source, MIAME compliant implementation of the Stanford Microarray Database (SMD). BMC Bioinformatics 4: 32.[CrossRef][Medline]
KIM, J., and V. R. IYER, 2004 Global role of TATA box-binding protein recruitment to promoters in mediating gene expression profiles. Mol. Cell. Biol. 24: 81048112.
KIM, K. S., and L. GUARENTE, 1989 Mutations that alter transcriptional activation but not DNA binding in the zinc finger of yeast activator HAPI. Nature 342: 200203.[CrossRef][Medline]
KING, D. A., L. ZHANG, L. GUARENTE and R. MARMORSTEIN, 1999 Structure of a HAP1/DNA complex reveals dramatically asymmetric DNA binding by a homodimeric protein. Nat. Struct. Biol. 6: 6471.[CrossRef][Medline]
LEE, H. C., T. HON and L. ZHANG, 2002 The Hsp90 molecular chaperone mediates heme activation of the yeast transcriptional activator Hap1. J. Biol. Chem. 277: 74307437.
LEE, H. C., T. HON, C. LAN and L. ZHANG, 2003 Structural environment dictates the biological significance of heme-responsive motifs and the role of Hsp90 in the activation of the heme activator protein Hap1. Mol. Cell. Biol. 23: 58575866.
LODI, T., and B. GUIARD, 1991 Complex transcriptional regulation of the Saccharomyces cerevisiae CYB2 gene encoding cytochrome b2: CYP1(HAP1) activator binds to the CYB2 upstream activation site UAS1B2. Mol. Cell. Biol. 11: 37623772.
LOMBARDIA, L. J., J. L. CADAHIA-RODRIGUEZ, M. A. FREIRE-PICOS, M. I. GONZALEZ-SISO, A. M. RODRIGUEZ-TORRES et al., 2000 Transcript analysis of 203 novel genes from Saccharomyces cerevisiae in hap1 and rox1 mutant backgrounds. Genome 43: 881886.[Medline]
LOWRY, C. V., and R. S. ZITOMER, 1988 ROX1 encodes a heme-induced repression factor regulating ANB1 and CYC7 of Saccharomyces cerevisiae. Mol. Cell. Biol. 8: 46514658.
MARTENS, J. A., and F. WINSTON, 2002 Evidence that Swi/Snf directly represses transcription in S. cerevisiae. Genes Dev. 16: 22312236.
MARTENS, J. A., and F. WINSTON, 2003 Recent advances in understanding chromatin remodeling by Swi/Snf complexes. Curr. Opin. Genet. Dev. 13: 136142.[CrossRef][Medline]
MENNELLA, T. A., L. G. KLINKENBERG and R. S. ZITOMER, 2003 Recruitment of Tup1-Ssn6 by yeast hypoxic genes and chromatin-independent exclusion of TATA binding protein. Eukaryot. Cell 2: 12881303.
MINER, J. N., M. I. DIAMOND and K. R. YAMAMOTO, 1991 Joints in the regulatory lattice: composite regulation by steroid receptor-AP1 complexes. Cell Growth Differ. 2: 525530.[Medline]
MORSE, R. H., 2000 RAP, RAP, open up! New wrinkles for RAP1 in yeast. Trends Genet. 16: 5153.[CrossRef][Medline]
ORLANDO, V., 2000 Mapping chromosomal proteins in vivo by formaldehyde-crosslinked-chromatin immunoprecipitation. Trends Biochem. Sci. 25: 99104.[CrossRef][Medline]
PFEIFER, K., T. PREZANT and L. GUARENTE, 1987 Yeast HAP1 activator binds to two upstream activation sites of different sequence. Cell 49: 1927.[CrossRef][Medline]
PFEIFER, K., K. S. KIM, S. KOGAN and L. GUARENTE, 1989 Functional dissection and sequence of yeast HAP1 activator. Cell 56: 291301.[CrossRef][Medline]
PINKHAM, J. L., Z. WANG and J. ALSINA, 1997 Heme regulates SOD2 transcription by activation and repression in Saccharomyces cerevisiae. Curr. Genet. 31: 281291.[CrossRef][Medline]
SCHNEIDER, J. C., and L. GUARENTE, 1991 Regulation of the yeast CYT1 gene encoding cytochrome c1 by HAP1 and HAP2/3/4. Mol. Cell. Biol. 11: 49344942.
SERTIL, O., R. KAPOOR, B. D. COHEN, N. ABRAMOVA and C. V. LOWRY, 2003 Synergistic repression of anaerobic genes by Mot3 and Rox1 in Saccharomyces cerevisiae. Nucleic Acids Res. 31: 58315837.
TURCOTTE, B., and L. GUARENTE, 1992 HAP1 positive control mutants specific for one of two binding sites. Genes Dev. 6: 20012009.
USHINSKY, S. C., and T. KENG, 1994 A novel allele of HAP1 causes uninducible expression of HEM13 in Saccharomyces cerevisiae. Genetics 136: 819831.[Abstract]
VERDIERE, J., M. GAISNE and B. R. LABBE, 1991 CYP1 (HAP1) is a determinant effector of alternative expression of heme-dependent transcribed genes in yeast. Mol. Gen. Genet. 228: 300306 (Erratum: Mol. Gen. Genet. 229 (2): 324).[Medline]
WINKLER, H., G. ADAM, E. MATTES, M. SCHANZ, A. HARTIG et al., 1988 Co-ordinate control of synthesis of mitochondrial and non-mitochondrial hemoproteins: a binding site for the HAP1 (CYP1) protein in the UAS region of the yeast catalase T gene (CTT1). EMBO J. 7: 17991804.[Medline]
ZHANG, L., and L. GUARENTE, 1994a Evidence that TUP1/SSN6 has a positive effect on the activity of the yeast activator HAP1. Genetics 136: 813817.[Abstract]
ZHANG, L., and L. GUARENTE, 1994b HAP1 is nuclear but is bound to a cellular factor in the absence of heme. J. Biol. Chem. 269: 1464314647.
ZHANG, L., and L. GUARENTE, 1994c The yeast activator HAP1a GAL4 family memberbinds DNA in a directly repeated orientation. Genes Dev. 8: 21102119.
ZHANG, L., and L. GUARENTE, 1996 The C6 zinc cluster dictates asymmetric binding by HAP1. EMBO J. 15: 46764681.[Medline]
ZHANG, L., and A. HACH, 1999 Molecular mechanism of heme signaling in yeast: the transcriptional activator Hap1 serves as the key mediator. Cell. Mol. Life Sci. 56: 415426.[CrossRef][Medline]
ZHANG, L., M. O. BERMINGHAM, B. TURCOTTE and L. GUARENTE, 1993 Antibody-promoted dimerization bypasses the regulation of DNA binding by the heme domain of the yeast transcriptional activator HAP1. Proc. Natl. Acad. Sci. USA 90: 28512855.
ZHANG, L., A. HACH and C. WANG, 1998 Molecular mechanism governing heme signaling in yeast: a higher-order complex mediates heme regulation of the transcriptional activator HAP1. Mol. Cell. Biol. 18: 38193828.
ZHAO, X. J., D. RAITT, P. V. BURKE, A. S. CLEWELL, K. E. KWAST et al., 1996 Function and expression of flavohemoglobin in Saccharomyces cerevisiae. Evidence for a role in the oxidative stress response. J. Biol. Chem. 271: 2513125138.
ZITOMER, R. S., and C. V. LOWRY, 1992 Regulation of gene expression by oxygen in Saccharomyces cerevisiae. Microbiol. Rev. 56: 111.
ZITOMER, R. S., P. CARRICO and J. DECKERT, 1997 Regulation of hypoxic gene expression in yeast. Kidney Int. 51: 507513.[Medline]
Communicating editor: F. WINSTONThis article has been cited by other articles:
![]() |
M. J. Hickman and F. Winston Heme Levels Switch the Function of Hap1 of Saccharomyces cerevisiae between Transcriptional Activator and Transcriptional Repressor Mol. Cell. Biol., November 1, 2007; 27(21): 7414 - 7424. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Shahi, K. Gulshan, and W. S. Moye-Rowley Negative Transcriptional Regulation of Multidrug Resistance Gene Expression by an Hsp70 Protein J. Biol. Chem., September 14, 2007; 282(37): 26822 - 26831. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Sun, T. Yu, and K.-C. Li Detection of eQTL modules mediated by activity levels of transcription factors Bioinformatics, September 1, 2007; 23(17): 2290 - 2297. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. MacPherson, M. Larochelle, and B. Turcotte A Fungal Family of Transcriptional Regulators: the Zinc Cluster Proteins Microbiol. Mol. Biol. Rev., September 1, 2006; 70(3): 583 - 604. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||